Development pipeline
Our pipeline
Working towards better cancer detection, treatment and prevention
Calviri is actively conducting an integrated set of studies and clinical trials that are at various stages to product. Studies target human and dog products against cancer and broadly preventative disease.
Human health
| Indication | Pre-clinical | Clinical/POC | Phase I | Phase II |
|---|---|---|---|---|
|
Breast cancer stage 1
|
||||
|
Colorectal cancer stage 1
|
||||
|
ICI response and adverse events predictor (multiple cancers)
|
||||
|
Renal Medullary Carcinoma (RMC) therapeutic
|
||||
|
Pediatric brain cancer NF1
|
||||
Calviri human health pipeline
A study to build a test to predict Checkpoint Inhibitors (ICIs) has been completed and is nearing publication. Read more here.
Early stage Breast Cancer and Colorectal cancer diagnostic studies are underway; a vaccine study is designed.
Human cancer prevention and treatment is an underserved and unmet need.
Animal health
| Indication | Pre-clinical | Clinical/POC | Phase I | Phase II |
|---|---|---|---|---|
|
HSA stage 1
|
||||
|
HSA therapeutic vaccine
|
||||
|
Preventative vaccine
|
||||
Calviri pipeline for dogs
The largest dog vaccine trial in the world is underway at three premier Veterinary Universities. The five-year trial will assess the performance of a preventative cancer vaccine. Read more.
HSA, Hemangiosarcoma is one of the most aggressive and common dog cancers. Both diagnostic and vaccine studies are ongoing.
The veterinary market for dogs is fast growing
We believe the world shouldn’t be hoping for a better solution to cancer, we should be demanding it.
Subscribe to receive email updates on our latest news and events.
"*" indicates required fields
